Select Publications
Journal articles
2024, 'The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia', Drug and Alcohol Review, 43, pp. 1256 - 1263, http://dx.doi.org/10.1111/dar.13845
,2024, 'Object oriented interviews in qualitative longitudinal research', Qualitative Research, http://dx.doi.org/10.1177/14687941241255248
,2024, 'Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence', International Journal of Drug Policy, 126, pp. 104359, http://dx.doi.org/10.1016/j.drugpo.2024.104359
,2024, 'Constitution of Long Covid illness, patienthood, and recovery: A critical synthesis of qualitative studies', BMJ Open, 14, pp. e083340, http://dx.doi.org/10.1136/bmjopen-2023-083340
,2024, 'In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination', BMJ Global Health, 9, pp. e014659, http://dx.doi.org/10.1136/bmjgh-2023-014659
,2024, 'Exhausting care: On the collateral realities of caring in the early days of the Covid-19 pandemic', Social Science and Medicine, 343, http://dx.doi.org/10.1016/j.socscimed.2024.116617
,2023, 'Situating 'best practice': Making healthcare familiar and good enough in the face of unknowns', SSM - Qualitative Research in Health, 4, pp. 100343, http://dx.doi.org/10.1016/j.ssmqr.2023.100343
,2023, 'Dosing practices made mundane: Enacting HIV pre-exposure prophylaxis adherence in domestic routines', Sociology of Health and Illness, 45, pp. 1747 - 1764, http://dx.doi.org/10.1111/1467-9566.13687
,2023, 'Caring for coca, living with chemicals: Towards ecological harm reduction', International Journal of Drug Policy, 120, http://dx.doi.org/10.1016/j.drugpo.2023.104179
,2023, 'The Fluid Hospital: On the Making of Care Environments in COVID-19', Health and Place, 83, pp. 103107 - 103107, http://dx.doi.org/10.1016/j.healthplace.2023.103107
,2023, 'Early warnings and slow deaths: A sociology of outbreak and overdose', International Journal of Drug Policy, 117, pp. 104065, http://dx.doi.org/10.1016/j.drugpo.2023.104065
,2023, 'Undoing elimination: Modelling Australia’s way out of the COVID-19 pandemic', Global Public Health, 18, pp. 2195899, http://dx.doi.org/10.1080/17441692.2023.2195899
,2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959
,2023, 'Navigating Chemical Toxicity in Coca Production in the Colombian Borderlands of Putumayo', Medical Anthropology: Cross Cultural Studies in Health and Illness, 42, pp. 650 - 666, http://dx.doi.org/10.1080/01459740.2023.2249202
,2023, 'Precarious Lives, Precarious Treatments: Making Drug Treatment Work in Northern Myanmar', Medical Anthropology: Cross Cultural Studies in Health and Illness, 42, pp. 4 - 20, http://dx.doi.org/10.1080/01459740.2022.2133706
,2023, 'Problematising the emergence of outbreak science in the governance of global health: making time for slow dis-ease', Critical Public Health, 33, pp. 838 - 847, http://dx.doi.org/10.1080/09581596.2023.2232523
,2023, 'Understanding how PrEP is made successful: Implementation science needs an evidence-making approach', Global Public Health, 18, pp. 2250426, http://dx.doi.org/10.1080/17441692.2023.2250426
,2022, 'How do care environments shape healthcare? A synthesis of qualitative studies among healthcare workers during the COVID-19 pandemic', BMJ Open, 12, pp. e063867, http://dx.doi.org/10.1136/bmjopen-2022-063867
,2022, 'Uncomfortable science: How mathematical models, and consensus, come to be in public policy', Sociology of Health and Illness: a journal of medical sociology, 44, pp. 1461 - 1480, http://dx.doi.org/10.1111/1467-9566.13535
,2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788
,2022, 'Making pandemics big: On the situational performance of Covid-19 mathematical models', Social Science and Medicine, 301, pp. 114907, http://dx.doi.org/10.1016/j.socscimed.2022.114907
,2022, 'The collective body: Legacies of monastic discipline in the post-Soviet prison', Theoretical Criminology, 26, pp. 57 - 74, http://dx.doi.org/10.1177/1362480620930677
,2022, 'Futuring a world without disease: visualising the elimination of hepatitis C', Critical Public Health, 32, pp. 153 - 167, http://dx.doi.org/10.1080/09581596.2020.1787347
,2022, 'New directions for participatory modelling in health: Redistributing expertise in relation to localised matters of concern', Global Public Health, 17, pp. 1827 - 1841, http://dx.doi.org/10.1080/17441692.2021.1998575
,2022, 'The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality', The Lancet, 399, pp. 61 - 116, http://dx.doi.org/10.1016/S0140-6736(21)01701-3
,2022, '“A matter of time”: Evidence-making temporalities of vaccine development in the COVID-19 media landscape', Time and Society, 31, pp. 132 - 154, http://dx.doi.org/10.1177/0961463X211032201
,2022, 'Different Paths and Potentials to Harm Reduction in Different Welfare States: Drug Consumption Rooms in the United Kingdom, Denmark, and France.', Am J Public Health, 112, pp. S99 - S103, http://dx.doi.org/10.2105/AJPH.2022.306790
,2021, 'Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103320
,2021, 'Mortality and AIDS-defining events among young people following transition from paediatric to adult HIV care in the UK', HIV Medicine, 22, pp. 631 - 640, http://dx.doi.org/10.1111/hiv.13096
,2021, 'Mapping drug epidemiology futures', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103378
,2021, 'Futures-oriented drugs policy research: Events, trends, and speculating on what might become', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2021.103332
,2021, 'Situating adherence to medicines: The embodied practices and hinterlands of HIV antiretrovirals', Sociology of Health and Illness, 43, pp. 1085 - 1099, http://dx.doi.org/10.1111/1467-9566.13270
,2021, 'Excitable models: Projections, targets, and the making of futures without disease', Sociology of Health and Illness, 43, pp. 859 - 880, http://dx.doi.org/10.1111/1467-9566.13263
,2021, 'Ecologies of drug war and more-than-human health: The case of a chemical at war with a plant', International Journal of Drug Policy, 89, http://dx.doi.org/10.1016/j.drugpo.2020.103067
,2021, 'How to think with models and targets: Hepatitis C elimination as a numbering performance', International Journal of Drug Policy, 88, http://dx.doi.org/10.1016/j.drugpo.2020.102694
,2021, 'Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limits', Health: an interdisciplinary journal for the social study of health, illness and medicine, http://dx.doi.org/10.1177/1363459320988887
,2021, '‘Sometimes I feel like the other life on heroin was better’: transitioning experiences towards methadone, and HIV prevention implications in Urban Kenya', Drugs: Education, Prevention and Policy, 28, pp. 246 - 254, http://dx.doi.org/10.1080/09687637.2020.1754764
,2021, 'Qualitative Analysis of Community Support to Methadone Access in Kenya', Substance Use and Misuse, 56, pp. 1312 - 1319, http://dx.doi.org/10.1080/10826084.2021.1922450
,2020, 'A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction', Harm Reduction Journal, 17, http://dx.doi.org/10.1186/s12954-020-00435-7
,2020, 'Towards an ontological politics of drug policy: Intervening through policy, evidence and method', International Journal of Drug Policy, 86, http://dx.doi.org/10.1016/j.drugpo.2020.102932
,2020, 'COVID-19 and the health of people who use drugs: What is and what could be?', International Journal of Drug Policy, 83, http://dx.doi.org/10.1016/j.drugpo.2020.102958
,2020, 'What prevents health policy being 'evidence-based'? New ways to think about evidence, policy and interventions in health', British Medical Bulletin, 135, pp. 38 - 49, http://dx.doi.org/10.1093/bmb/ldaa026
,2020, 'More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services', International Journal of Drug Policy, 82, http://dx.doi.org/10.1016/j.drugpo.2020.102771
,2020, 'Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy', The Lancet Gastroenterology and Hepatology, 5, pp. 641 - 642, http://dx.doi.org/10.1016/S2468-1253(20)30158-8
,2020, 'Modelling the pandemic: Attuning models to their contexts', BMJ Global Health, 5, pp. e002914, http://dx.doi.org/10.1136/bmjgh-2020-002914
,2020, '“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination', International Journal of Drug Policy, 80, http://dx.doi.org/10.1016/j.drugpo.2019.02.008
,2020, 'A model society: maths, models and expertise in viral outbreaks', Critical Public Health, 30, pp. 253 - 256, http://dx.doi.org/10.1080/09581596.2020.1748310
,2020, 'Mathematical models as public troubles in COVID-19 infection control: following the numbers', Health Sociology Review, 29, pp. 177 - 194, http://dx.doi.org/10.1080/14461242.2020.1764376
,2020, 'Editing the International Journal of Drug Policy', International Journal of Drug Policy, 76, pp. 102664, http://dx.doi.org/10.1016/j.drugpo.2020.102664
,2020, 'Making evidence and policy in public health emergencies: Lessons from COVID-19 for adaptive evidence-making and intervention', Evidence and Policy, 16, pp. 477 - 490, http://dx.doi.org/10.1332/174426420X15913559981103
,